ロード中...
Intense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis
PURPOSE: To evaluate the intense pulsed light (IPL) therapy with optimal pulse technology (OPT, M22™, Lumenis, USA) as an adjunct therapy for the prevention of recurrences in moderate to severe blepharokeratoconjunctivitis (BKC). METHODS: This open-label nonrandomized clinical trial evaluated 33 pat...
保存先:
| 出版年: | J Ophthalmol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6766164/ https://ncbi.nlm.nih.gov/pubmed/31637051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3143469 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|